Table 2.
Oral | Intravenous/ intramuscular | No. of patients | Patterns of systemic antibiotic use |
||||
---|---|---|---|---|---|---|---|
DDDs | % DDDs | DDDs/1000 patient-days | DDDs/100 admissions | ||||
Antibiotic name | |||||||
cephalosporins J01D | 5 | 398 | 403 | 409.5 | 21 | 109.5 | 53.7 |
combinations of sulphonamides with trimethoprim J01EE | 162 | 0 | 162 | 358.0 | 18 | 95.7 | 47.0 |
fluoroquinolones J01MA | 33 | 99 | 132 | 342.9 | 17 | 91.7 | 45.0 |
imidazole derivatives J01XDa | 60 | 188 | 248 | 311.4 | 16 | 83.3 | 40.9 |
macrolides, lincosamides and streptogramins J01F | 56 | 1 | 57 | 248.5 | 13 | 66.5 | 32.6 |
penicillins J01C | 84 | 28 | 112 | 227.4 | 11 | 60.8 | 29.8 |
antimycobacterials J04B | 5 | 0 | 5 | 56.0 | 3 | 15.0 | 7.3 |
aminoglycosides J01G | 0 | 11 | 11 | 15.0 | 1 | 4.0 | 2.0 |
tetracyclines J01A | 5 | 0 | 5 | 16.0 | 1 | 4.3 | 2.1 |
carbapenems J01DH | 0 | 1 | 1 | 0.3 | 0 | 0.1 | 0.0 |
total | 1985.0 | 530.9 | 260.5 | ||||
Route of antibiotic administration | |||||||
oral | 112 | 1024.8 | 52 | 274.1 | 134.5 | ||
parenteral (intravenous/intramuscular) | 491 | 960.2 | 48 | 256.8 | 126.0 | ||
total | 603 | 1985.0 | 100 | 530.9 | 260.5 |
aParenteral formulations of nitroimidazoles are classified as J01XD and oral formulations as P01AB in the WHO ATC/DDD index.